Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD: an analysis from FIDELITY

S. E. Inzucchi; G. Filippatos; S. D. Anker; C. Wanner; T. Shafi; N. Tangri; B. Pitt; R. Weingold; M. Brinker; C. Scott; L. Roberts; P. Rossing

doi:10.1007/s00125-023-05969-6

Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD: an analysis from FIDELITY

S. E. Inzucchi, G. Filippatos, S. D. Anker, C. Wanner, T. Shafi, N. Tangri, B. Pitt, R. Weingold, M. Brinker, C. Scott, L. Roberts, P. Rossing

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Tidsskrift	Diabetologia
Vol/bind	66
Udgave nummer	SUPPL 1, 1
Sider (fra-til)	S354-S355
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-023-05969-6
Status	Udgivet - 1 sep. 2023
Begivenhed	59th EASD Annual Meeting: EASD 2023 - Hamburg Exhibition and Congress, Hamborg, Tyskland Varighed: 2 okt. 2023 → 6 okt. 2023 Konferencens nummer: 59 https://www.easd.org/annual-meeting/easd-2023.html

Konference

Konference	59th EASD Annual Meeting: EASD 2023
Nummer	59
Lokation	Hamburg Exhibition and Congress
Land/Område	Tyskland
By	Hamborg
Periode	02/10/2023 → 06/10/2023
Internetadresse	https://www.easd.org/annual-meeting/easd-2023.html

Adgang til dokumentet

10.1007/s00125-023-05969-6

Andre filer og links

Link to publication in Scopus

Citationsformater

Inzucchi, S. E., Filippatos, G., Anker, S. D., Wanner, C., Shafi, T., Tangri, N., Pitt, B., Weingold, R., Brinker, M., Scott, C., Roberts, L., & Rossing, P. (2023). Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD: an analysis from FIDELITY. Diabetologia, 66(SUPPL 1, 1), S354-S355. https://doi.org/10.1007/s00125-023-05969-6

Inzucchi, SE, Filippatos, G, Anker, SD, Wanner, C, Shafi, T, Tangri, N, Pitt, B, Weingold, R, Brinker, M, Scott, C, Roberts, L & Rossing, P 2023, 'Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD: an analysis from FIDELITY', Diabetologia, bind 66, nr. SUPPL 1, 1, s. S354-S355. https://doi.org/10.1007/s00125-023-05969-6

@article{38339fcc463741e9864960369486f701,

title = "Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD: an analysis from FIDELITY",

author = "Inzucchi, {S. E.} and G. Filippatos and Anker, {S. D.} and C. Wanner and T. Shafi and N. Tangri and B. Pitt and R. Weingold and M. Brinker and C. Scott and L. Roberts and P. Rossing",

note = "59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Hamburg, GERMANY, OCT 02-06, 2023; 59th EASD Annual Meeting: EASD 2023, EASD 2023 ; Conference date: 02-10-2023 Through 06-10-2023",

year = "2023",

month = sep,

day = "1",

doi = "10.1007/s00125-023-05969-6",

language = "English",

volume = "66",

pages = "S354--S355",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "SUPPL 1, 1",

url = "https://www.easd.org/annual-meeting/easd-2023.html",

}

TY - ABST

T1 - Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD: an analysis from FIDELITY

AU - Inzucchi, S. E.

AU - Filippatos, G.

AU - Anker, S. D.

AU - Wanner, C.

AU - Shafi, T.

AU - Tangri, N.

AU - Pitt, B.

AU - Weingold, R.

AU - Brinker, M.

AU - Scott, C.

AU - Roberts, L.

AU - Rossing, P.

N1 - Conference code: 59

PY - 2023/9/1

Y1 - 2023/9/1

UR - http://www.scopus.com/inward/record.url?scp=85171807264&partnerID=8YFLogxK

U2 - 10.1007/s00125-023-05969-6

DO - 10.1007/s00125-023-05969-6

M3 - Conference abstract in journal

SN - 0012-186X

VL - 66

SP - S354-S355

JO - Diabetologia

JF - Diabetologia

IS - SUPPL 1, 1

T2 - 59th EASD Annual Meeting: EASD 2023

Y2 - 2 October 2023 through 6 October 2023

ER -